Migraine
Not recruitingStudy on Atogepant for Preventing Menstrual Migraine in Women
Study on Atogepant for Preventing Menstrual Migraine in Women
Germany- Participants:18–64 years
- Substances:Atogepant
- Sponsor:AbbVie Deutschland GmbH & Co. KG
Rare diseases
Investigational molecules
Locations
Back to Germany1 867 clinical trials in Blankenfelde-Mahlow, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Atogepant for Preventing Menstrual Migraine in Women
GermanyStudy of BI-1607, Ipilimumab, and Pembrolizumab for Patients with Advanced Melanoma
GermanyStudy on the Effectiveness of Cabotegravir and Rilpivirine for People with HIV-1 Who Have Not Responded Well to Oral Treatment
GermanyStudy of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia
GermanyStudy on the Safety of INF904 for Patients with Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa
GermanyStudy of Weekly Oral GS-1720 and GS-4182 for People with HIV-1 Who Are Virologically Suppressed
GermanyStudy on the Effects of Deucravacitinib for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on Long-Term Safety of Briquilimab for Patients with Chronic Urticaria
GermanyStudy of Amlenetug for Patients with Multiple System Atrophy
GermanyStudy of Eftilagimod Alfa with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer
GermanyStudy to Evaluate the Effectiveness of Survodutide in Reducing Liver Fat and Weight in Patients with Obesity or Overweight and Non-Alcoholic Steatohepatitis (NASH)
GermanyStudy on Reducing Treatment Intensity for Patients with HPV-Positive Oropharyngeal Cancer Using Cisplatin and Carboplatin
GermanyThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating new therapeutic approaches for moderate to severe plaque psoriasis, including multiple clinical trials testing novel treatments and comparing their effectiveness to existing options.
Multiple promising compounds being investigated to expand treatment options for patients with persistent symptoms.
Innovative research focusing on moderate to severe atopic dermatitis, investigating both standalone treatments and combination therapies with topical corticosteroids.
Emphasis on developing solutions for patients who haven't responded well to conventional treatments.
Research encompassing various skin conditions including chronic hand eczema, vitiligo, and hidradenitis suppurativa.
Focus on developing effective treatments for conditions that significantly impact quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.